Shenzhen Neptunus Interlong Bio-technique Company Limited 08329.HKの前四半期の収益はどうでしたか?
Shenzhen Neptunus Interlong Bio-technique Company Limitedの収益見積もりはいくらですか?
Shenzhen Neptunus Interlong Bio-technique Company Limitedの収益品質スコアはどれくらいですか?
Shenzhen Neptunus Interlong Bio-technique Company Limitedはいつ収益を報告しますか?
Shenzhen Neptunus Interlong Bio-technique Company Limitedの予想収益はいくらですか?
Shenzhen Neptunus Interlong Bio-technique Company Limitedは収益予想を上回りましたか?
主要データ
前終値
$0.158
始値
$0.158
当日レンジ
$0.153 - $0.162
52週レンジ
$0.131 - $0.38
取引高
770.0K
平均取引高
428.6K
1株当たり利益(TTM)
0.00
配当利回り
--
時価総額
$68.5M
NEP INTERLONGとは何ですか?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines, and healthcare food products. The company is headquartered in Shenzhen, Guangdong and currently employs 1,474 full-time employees. The company went IPO on 2005-09-12. The firm operates its businesses through two segments. The Manufacturing and Selling of Medicines and Medical Devices segment is mainly engaged in manufacturing, sales of medicines and medical devices. The Sales and Distribution of Medicines, Healthcare Products and Medical Devices segment is mainly engaged in sales and distribution of medicines, healthcare products and medical devices. The firm mainly operates its businesses in the domestic market.